Abstract
In vivo nuclear magnetic resonance spectroscopy (MRS) of the human brain is a recently developed technique which allows to assay noninvasively in vivo key molecules of brain metabolism. After a review of the origin of the signals detected by phosphorus and proton MRS of human brain, the impact of MRS on clinical neurology is examined. MRS of the brain does not purport to be a metabolic “biopsy”, but unique applications for brain MRS are (1) quantitating the oxidative state of the brain and defining neuronal death, (2) assessing and mapping neuron damage, (3) evaluating membrane alterations, and (4) characterizing encephalopathies. In the near future brain MRS will be performed routinely after conventional MRI, as a valuable metabolic (and functional) complement to the anatomical evaluation of cerebral pathologies, particularly the toxic, metabolic and infectious encephalopathies.
Article PDF
Avoid common mistakes on your manuscript.
References
Adalsteinsonn E, Spielman DM, Wright GA, Pansy JM, Meyer CH, Macovski A (1993) Incorporating lactate/lipid discrimination into a spectroscopic imaging sequence. Magn Reson Med 30:124–130
Agranoff BW (1989) Lipids. In: Siegel G, Agranoff B, Alberts RW, Molinoff P (eds) Basic Neurochemistry, 4th edn. Raven Press, New York, pp 91–107
Aichner F, Felber S, Birbamer G, Luz G, Judmaier W, Schutzhard E (1992) Magnetic resonance: a non invasive approach to metabolism, circulation and morphology in human brain death. Ann Neurol 32:507–511
Albin RL, Greenamyre JT (1992) Alternative excitotoxic hypotheses. Neurology 42:733–738
Alger JR, Symko SC, Bizzi A, Posse S, DesPres D, Armstrong MR (1993) Absolute quantitation of short TE brain 1-H MR spectra and spectroscopic imaging data. J Comput Assist Tomogr 17:191–199
Arnold DL, Shoubridge EA, Villemure J-G, Feindel W (1990) Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo: preliminary observations on tumor grading. NMR Biomed 3:184–189
Arnold DL, Emrich JF, Shoubridge EA, Villemure J-G, Feindel W (1991) Characterization of astrocytomas, meningiomas, and pituitary adenomas by phosphorus magnetic resonance spectroscopy. J Neurosurg 74:447–453
Arnold DL, Matthews PM, Francis GS, O'Connor J, Antel JP (1992) Proton Magnetic Resonance spectroscopic imaging for metabolites characterization of demyelinating plaques. Ann Neurol 31:235–241
Asrup J, Siesjo BK, Symon L (1981) Thresholds in cerebral ischemia; the ischemic penumbra. Stroke 6:723–725
Austin SJ, Connelly A, Gadian DG, Benton JS, Brett EM (1991) Localized H-1 NMR spectroscopy in Canavan's disease: a report of two cases. Magn Reson Med 19:439–445
Azzopardi D, Wyatt JS, Cady EB, Delpy DT, Baudin J, Stewart AL, Hope PL, Hamilton PA, Reynolds EOR (1989) Prognosis of newborn infants with hypoxic-ischemic brain injury assessed by phosphorus magnetic resonance spectroscopy. Pediatr Res 25:445–451
Bachelard H, Badar-Gofer R (1993) NMR spectroscopy in Neurochemistry. J Neurochem 61:412–429
Bain PG, O'Brien MD, Keevil SF, Porter DA (1992) Familial periodic cerebellar ataxia: a problem of cerebellar intracellular pH homeostasis. Ann Neurol 31:147–154
Barbiroli B, Mantagna P, Cortelli P, Funicello R, Iotii S, Monari L, Pierangeli G, Zaniol P, Lugaresi E (1992) Abnormal brain and muscle energy metabolism shown by P-31 magnetic resonance spectroscopy in patients affected by migraine with aura. Neurology 42:1209–1214
Barker PB, Bryan RN, Kumar AJ, Naidu S (1992) Proton NMR spectroscopy of Canavan's disease. Neuropediatrics 23:263–267
Beal MF, Human BT, Korshetz W (1993) Do defect in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci 16:125–131
Behar KL, Ogino T (1993) Characterization of macromolecules resonances in the 1-H NMR spectrum of rat brain. Magn Reson Med 30:38–44
Beckmann N, Turkalj I, Seelig J, Keller U (1991) 13-C NMR for the assessment of human brain glucose metabolism in vivo. Biochemistry 30:6362–6366
Berkelbach van der Sprenkel JW, Knufman NMJ, Van Rijen PC, Luyten PR, Den Holander JA, Tulleken CAF (1992) Proton spectroscopic imaging in cerebral ischaemia. Where we stand, and what can be expected. Adv Tech Stand Neurosurg 19:3–17
Birken DL, Oldendorf WH (1989) N-Acetyl-aspartic acid: a literature review of a compound prominent in H1-NMR spectroscopic studies of the brain. Neurosci Behav Rev 13:23–31
Blakely RD (1988) The Neurobiology of N-acetylaspartylglutamate. Int Rev Neurobiol 30:39–100
Blass JP, Shen RKF, Cerdabaum JM (1988) Energy metabolism in disorders of the nervous system. Rev Neurol (Paris) 144:543–563
Boesch C, Gruetter R, Martin E, Duc G, Wütrich K (1989) Variations in the in vivo P-31 MR spectra of the developing brain during post-natal life. Radiology 172:197–199
Bottomley PA (1987) Spatial localization in NMR spectroscopy in vivo. Ann NY Acad Sci 508:333–348
Bottomley PA (1989) Human in vivo NMR spectroscopy in diagnostic medicine: clinical tool or research probe? Radiology 170:1–15
Bottomley PA, Hardy CJ (1989) Rapid, reliable, in vivo assays of human phosphate metabolites by nuclear magnetic resonance. Clin Chem 35:392–395
Bottomley PA, Hardy CJ, Cousins JP, Amstrong M, Wagle WA (1990) AIDS dementia complex: brain energy phosphate metabolic deficit. Radiology 176:407–411
Bottomley PA, Cousins JP, Hardy DJ, Pendrey DL, Wagle WA, Hardy CJ, Eames FA, McCafrey RJ, Thomson DA (1992) Alzheimer dementia: quantification of energy metabolism and mobile phosphoesters with P-31 NMR spectroscopy. Radiology 183:695–699
Brenner RE, Munro PMG, Williams SCR, Bell JD, Barker GJ, Hawkins CP, Landon DN, Donald WI (1993) The proton NMR spectrum in acute EAE: the significance of the change in Cho: Cr ratio. Magn Reson Med 29:737–745
Brenton DP, Garrod PJ, Krywawhych S, Reynolds EOR, Bachelard HS, Cox DW, Morris PG (1985) Phosphoethanolamine is a major constituent of phosphomonoester peak detected by P-31 NMR in newborn brain. Lancet I, 115
Brown GG, Levine SR, Petegreew JW, Gdowski JW, Bueri JA, Helpern JA, Welch KMA (1989) In vivo 31-P NMR profiles of Alzheimer's disease and multiple subcortical infarct dementia. Neurology 39:1423–1427
Brown TR, Kincaid BM, Ugurbil K (1982) NMR chemical shift Imaging in three demensions. Proc Natl Acad Sci USA 79:3523–3526
Browning JL (1981) NMR studies of the structural and motionnal properties of phospholipids in membranes. In: Knight R (ed) Liposomes: from physical structure to therapeutic applications. Elsevier North Holland, Amsterdam, pp 189–242
Bruhn H, Frahm J, Gyngell M, Merbold KD, Hanïcke W, Sauter R (1989) Cerebral metabolism in man after acute stroke: new observation using localized proton NMR spectroscopy. Magn Reson Med 9:126–131
Bruhn H, Frahm J, Gyngell M, Merbold KD, Hanïcke W, Sauter R, Hamburger C (1989) Non invasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo. Initial experience in patients with cerebral tumors. Radiology 172:541–548
Bruhn H, Kruse B, Korenke GC, Manefeld F, Hänïcke W, Merboldt KD, Frahm J (1992) Proton NMR spectroscopy of cerebral metabolic alterations in infantile peroxisomal disorders. J Comput Assist Tomogr 16:335–344
Bruhn H, Michaelis T, Merbold KD, Hanïcke W, Gyngell M, Hamburger C, Frahm J (1992) On the interpretation of proton NMR spectra from brain tumors in vivo and in vitro. NMR Biomed 5:253–258
Bruhn H, Frahm J, Merbold KD, Hanïcke W, Hanefeld F, Christen HJ, Kruse B, Bauer HJ (1992) Multiple sclerosis in children: cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo. Ann Neurol 32:140–150
Carter CJ, Benavidés J, Dubois A (1989) The biochemistry of Huntington's disease chorea. In: Quinn NP, Jenner PG (eds) Disorders of movement: clinical, pharmacological and physiological aspects, vol 34. Academic Press, London, pp 468–494
Cervos-Navarro J, Diemer NH (1991) Selective vulnerability in brain hypoxia. Crit Rev Neurobiol 6:149–182
Chance B (1989) What are the goals of magnetic resonance research. NMR Biomed 2:179–187
Choi DW (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:633–634
Chong WK, Sweeney B, Wilkinson ID, Paley M, Hall-Craggs MA, Kendall BE, Shepard JK, Beecham M, Miller RF, Weller IVD, Newman SP, Harrisson MJ (1993) Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings. Radiology 188:119–124
Clarke DD, Lajtha AL, Maker HS (1989) Intermediary metabolism. In: Siegel G, Agranoff B, Alberts RW, Molinoff P (eds) Basic neurochemistry, 4th edn. Raven Press, New York, pp 541–564
Commodari F, Arnold DL, Sanctuary BC, Shoubridge EA (1991) H-1 NMR characterization of normal cerebrospinal fluid and the detection of methylmalonic acid in a vitamin B 12 deficient patient, NMR Biomed 4:192–200
Confort-Gouny S, Vion-Dury J, Cozzone PJ (1992) Méthodes de localisation du signal de RMN in vivo. Vers une approche métabolique des pathologies. J Radiol (Paris) 73:13–21
Confort-Gouny S, Chabrol B, Vion-Dury J, Mancini J, Cozzone PJ (1993) MRI and localized proton MRS in an early infantile form of neuronal ceroid-lipofuscinosis. Pediatr Neurol 9:57–60
Confort-Gouny S, Vion-Dury J, Ncoli F, Dano P, Donnet A, Grazziani N, Gastaut JL, Grisoli F, Cozzone PJ (1993) A multiparametric data analysis showing the potential of localized proton MR spectroscopy of the brain in the metabolic definition of neurological diseases. J Neurol Sci 118:123–133
Confort-Gouny S, Vion-Dury J, Chabrol B, Nicoli F, Cozzone PJ (1993) Localized proton MR spectroscopy in X-linked adrenoleukodystrophy. 12th Annual meeting of the Society of Magnetic Resonance in Medicine, New York. Book of abstracts, p 1565
Connely A, Cross JH, Gadian DG, Hunter JV, Kirkham FJ Leonard JV (1993) Magnetic resonance spectroscopy shows increased brain glutamine in ornithine carbamoyl transferase deficiency. Pediatr Res 33:77–81
Corbett RJT, Laptook AR, Garcia D, Ruley JI (1992) Cerebral acid buffering capacity at different ages measured in vivo by P-31 and H1 nuclear magnetic resonance spectroscopy. J Neurochem 59:216–226
Christiansen P, Jenriksen O, Subgaard M, Gideon P, Larsson HBW (1993) In vivo quantification of brain metabolites by 1H-MRS using water as and internal standard. Magn Reson Imaging 11:107–118
Dager SR, Marro KI, Richards TL, Matzger GD (1992) Localized magnetic resonance spectroscopy measurement of brain lactate infusion in healthy volunteers. Life Sci 51:973–985
Degani H, Alger JR, Shulman RG, Petroff OAC, Prichard JW (1987) 31P Magnetization transfer studies of creatine kinase kinetics in living rabbit brain. Magn Reson Med 5:1–12
Deicken RE, Hubesch B, Jensen PC, Sappey-Marinier D, Krell P, Wisniewski A, Vanderburg D, Parks R, Fein G, Weiner MW (1991) Alteration in brain phosphate metabolic concentrations in patients with human immunodeficiency virus infection. Arch Neurol 48:203–209
Delivoria-Papadopoulos M, DiGiacomo JE (1990) 31-P nuclear magnetic resonance spectroscopy in the human neonatal brain. Semin Perinatol 14:248–257
Demaerel P, Johannik K, Van Hecke PV, Van Ongeval C, Verellen S, Marchal G, Wilms G, Plets C, Goffn J, Van Callenbergh F, Lammens M, Baert AL (1991) Localized H-1 NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors. J Comput Assist Tomogr 15:67–76
Detre JA, Wang Z, Bogdan AR, Gusnar DA, Bay CA, Bingham PM, Zimmerman RA (1991) Regional variations in brain lactate in Leigh syndrome by localized 1H magnetic resonance spectroscopy. Ann Neurol 29:218–221
Duijn JH, Matson GB, Maudsley AA, Hugg JW, Weiner MW (1992) Human brain infarction: proton MR spectroscopy. Radiology 183:711–718
Duijn JH, Matson GB, Maudsley AA, Weiner MW (1992) 3D-Phase encoding 1H spectroscopic imaging on human brain. Magn Reson Imaging 10:315–319
Duijn JH, Gillen J, Sobering G, Zijl PCM van, Moonen CTW (1993) Multisection proton imaging of the brain. Radiology 188:277–282
Eleff SM, Barker PB, Blackband J, Chatham JC, Lutz NW, Johns DR, Bryan RN, Hurko O (1990) Phosphorus magnetic resonance spectroscopy of patients with mitochondrial cytopathies demonstrate: low levels of brain phosphocreatine. Ann Neurol 27:626–630
Faden AI, Salzman S (1992) Pharmacological strategies in CNS trauma. Trends Pharmacol Sci 13:29–35
Farooqui AA, Horroks LA (1991) Excitatory amino-acid receptors, neural membrane phospholipid metabolism and neurological disorders. Brain Res Rev 16:171–191
Felber SR, Aichner FT, Sauter R, Gerstenbrand F (1992) Combined magnetic resonance imaging and proton magnetic resonance spectroscopy of patients with acute stroke. Stroke 23:1106–1110
Felber SR, Sperl W, Chemelli A, Murr C, Wendel U (1993) Maple syrup urine disease: metabolic decompensation monitored by proton magnetic resonance imaging and spectroscopy. Ann Neurol 33:396–401
Fishman RA (1989) Brain edema and disorders of intracranial pressure. In: Rowland LP (ed) Merritt's textbook of neurology. Lea and Febinger, Philadelphia, pp 262–271
Flynn CJ, Farooqui AA, Horroks LA (1989) Ischaemia and hypoxia. In: Siegel G, Agranoff B, Alberts RW, Molinoff P (eds) Basic neurochemistry, 4th edn. Raven Press, New York, pp 783–795
Ford CC, Griffey RH, Matwiyoff NA, Rosenberg GA (1992) Multivoxel H1-MRS of stroke. Neurology 42:1408–1412
Frahm J, Michaelis T, Merboldt K-D, Hänicke W, Gyngell ML, Chien D, Bruhn H (1989) Localized NMR spectroscopy in vivo progress and problems. NMR Biomed 2:188–195
Frahm J, Bruhn H, Hänïcke W, Merboldt K-D, Mursch K, Markakis E (1991) Localized proton NMR spectroscopy of brain tumors using short echo time STEAM sequences. J Comput Assist Tomogr 15:915–922
Frahm J, Michaelis T, Merboldt K-D, Hänïcke W, Gyngell ML, Bruhn H (1991) On the N-acetyl-methyl-resonance in localized 1H NMR spectra of human brain in vivo. NMR Biomed 4:201–211
Federico A, Dotti MT, Meloni M, Gagelli E, Vivi A, Valensin G (1988) H-1 NMR analysis of CSF in normal subjects and in a case of mitochondrial encephal-neuro-myopathy. Magn Res Med Biol 1:305–313
Fulham M, Bizi A, Dietz MJ, Shih HHL, Raman R, Sobering GS, Frank JA, Dwyer AJ, Alger JR, Di Chiro G (1992) Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 185:675–686
Gadian DG, Shaw D, Moonen CTW, Zijl P van (1993) Advances in proton magnetic resonance spectroscopy of the brain. A report of a workshop held in Oxford. Magn Reson Med 30:1–3
Gadian DG, Williams SR, Bates TE, Kaupine RA (1993) Brain damage studied by NMR and other methods: NMR spectroscopy, current status and future possibilities. Acta Neurochir (Wien) [Suppl] 57:1–8
Gibson GE, Pulsinelli W, Blass J, Duffy TE (1981) Brain dysfunction in mild to moderate hypoxia. Am J Med 70:1247–1254
Gideon P, Henriksen O, Sperling B, Christiansen P, Skyhoj Olsen T, Jorgensen HS, Arlien-Soborg P (1992) Early time course of N-acetyl-aspartate, creatine and phosphocreatine and compounds containing choline in the brain after acute stroke. A proton magnetic resonance spectroscopy study. Stroke 23:1566–1572
Goplerud JM, Delivoria-Papadopoulos M (1993) Nuclear magnetic resonance imaging and spectroscopy following asphyxia. Clin Perinatol 20:345–367
Graham GG, Blamire AM, Howseman AM, Rothman DL, Fayad PB, Brass LM, Petroff OAC, Schulman RG, Pritchard JW (1992) Proton magnetic resonance spectroscopy of cerebral lactate and other metabolites in stroke patients. Stroke 23:333–340
Griffey RH, Brown MS, Bankhurst AD, Sibbit RR, Sibbit WL (1990) Depletion of high-energy phosphates in the central nervous system of patients with systemic lupus erythematosus, as determined by phosphorus-31 nuclear resonance spectroscopy. Arthritis Rheum 33:827–833
Grodd W, Krageloh-Mann I, Klose U, Sauter R (1991) Metabolic and destructive brain disorders in children: findings with localized proton localized MR spectroscopy. Radiology 481:173–181
Grossman RI, Lenkinski RE, Ramer KN, Gonzalez-Scarano F, Cohen JA (1992) MR proton spectroscopy in multiple sclerosis. Am J Neuroradiol 13:1535–1543
Grutter R, Rothman DL, Novotny EJ, Shulman GI, Pricard JW, Shulman RG (1992) Detection and assignment of the glucose signal in H1 NMR difference spectra of the human brain. Magn Reson Med 27:183–188
Gupta RK, Moore RD (1980)31P NMR studies of intracellular free Mg2+ in intact frog squelettal muscle. J Biol Chem 255:387–399
Gupta RK, Saraswat VA, Poptani H, Dhilman RK, Kohli A, Gujral RB, Naik SR (1993) Magnetic resonance imaging and localized in vivo proton spectroscopy in patients with fulminant hepatic failure. Am J Gastroenterol 88:670–674
Hacke W, Hennerici M, Gelmers HJ, Kramer G (1991) Cerebral ischaemia. Springer, Berlin Heidelberg New York
Halvorson HR, Vande Linde AMQ, Helpern JA, Welch KM (1992) Assessment of magnesium concentrations by 31-P NMR in vivo. NMR Biomed 5:53–58
Hanstock CC, Rothman DL, Prichard JW, Jue T, Shulman RG (1988) Spatially localized 1H-NMR spectra of metabolites in the human brain. Proc Natl Acad Sci USA 185:1821–1825
Heindel W, Kugel H, Toth B (1993) Non invasive detection of increased glycine content by proton NMR spectroscopy in the brains of two infants with non ketotic hyperglycinemia. Am J Neuroradiol 14:629–635
Hennig J, Pfister H, Ernst T, Ott D (1992) Direct absolute quantification of metabolites in the human brain with in vivo localized proton spectroscopy. NMR Biomed 5:193–199
Herholz K, Heindel W, Luyten PR, Den Hollender JA, Pietrzyk U, Voges J, Kugel H, Friedmann G, Heiss WD (1992) In vivo imaging of glucose consumption and lactate concentration in human gliomas. Ann Neurol 31:319–327
Herschap A (1992) Current status of human in vivo NMR spectroscopy. Eur J Radiol 14:117–123
Herz L (1989) Is Alzheimer's disease and anterograde degeneration, originating in the brain stem, and disrupting metabolic and functional interaction between neurons and glial cells? Brain Res Rev 14:335–353
Hubesch B, Sappey-Marinier D, Roth K, Meyerhoff DJ, Matson GB, Weiner MW (1990) P-31 MR spectroscopy of normal human brain and brain tumors. Radiology 174:401–409
Hugg JW, Matson GB, Twieg DB, Maudsley AA, Sappey-Marinier D, Weiner MW (1992) Phosphorus-31 MR spectroscopic imaging (MRSI) of normal and pathological human brains. Magn Reson Imaging 10:227–243
Hugg JW, Duijn JH, Matson GB, Maudsley AA, Tsuruda JS, Gelinas DF, Weiner MW (1992) Elevated lactate and alkalosis in chronic human brain infarction observed by H-1 and 31P MR spectroscopic imaging. J Cereb Blood Flow Metab 12:734–744
Hugg JW, Laxer KD, Matson GB, Maudsley AA, Husted CA, Weiner MW (1992) Lateralization of human focal epilepsy by P-31 magnetic resonance spectroscopic imaging. Neurology 42:2011–2018
Hugg JW, Laxer KD, Matson GB, Maudsley AA, Weiner MW (1993) Neurons loss localizes focal epilepsy by proton MR spectroscopic imaging. Ann Neurol 34:788–794
Hüppi PS, Posse S, Lazeyras F, Burri R, Bossi E, Hershkowitz N (1991) Magnetic resonance in preterm and term newborns: 1H spectroscopy in developing human brain. Pediatr Res 30:574–578
Huxtable RJ (1989) Taurine in the central nervous system and the mammalian actions of taurine. Prog Neurobiol 32:471–533
Ikeda Y, Lond DM (1990) Molecular basis of brain injury and brain edema: the role of oxygen and free radicals. Neurosurgery 27:1–11
Isacson O (1993) On neuronal health. Trends Neurosci 16:306–308
Jenkins BG, Koroshetz WJ, Beal FM, Rosen BR (1992) Evidence for an energy metabolism defect in Huntington's disease using localized proton NMR spectroscopy. 11th Annual meeting of the Society of Magnetic Resonance in Medicine, Berlin Book of abstracts, p 755
Jope RS, Jenden DJ (1979) Choline and phospholipid metabolism and the synthesis of acetylcholine in the rat brain. J Neurosci Res 4:69–82
Jingling FD, Wakhloo AK, Hennig J (1993) In vivo proton spectroscopy of meningioma after preoperative embolization. Magn Reson Med 30:155–160
Kanashiro M, Naritomi H, Sasaki M, Tsuji S, Miyake Y (1990) Non invasive 31P NMR study on the develop ment of brain membranes of gerbils and jimpy mice, a myelin deficient mutant. Physiol Chem Phys Med NMR 22:141–154
Kato T, Tokumaru A, O'uchi T, Mikami I, Umeda M, Nose K, Egushi T, Hasegawa M, Okuyama K (1991) Assessment of brain death in children by means of P-31 MR spectroscopy: preliminary note. Radiology 179:95–99
Kato T, Takahashi S, Shioiri T, Inubushi T (1993) Alterations in brain phosphorus metabolism in bipolar disorder detected in vivo 31-P and 7-Li magnetic resonance spectroscopy. J Affect Disord 27:53–60
Kauppinen RA (1993) 1-H Nuclear magnetic resonance spectroscopy identifies neural cell types: a promis ing step for neuroimaging? Trends Neurosci 16:384–386
Kauppinen RA, Williams SR, Busza AL, Van Bruggen N (1993) Applications of magnetic resonance spectroscopy and diffusion-weighted imaging to the study of brain biochemistry and pathology. Trends Neurosci 16:88–95
Kauppinen RA, Niskanen T, Hakumäki J, Williams SR (1993) Quantitative analysis of 1H NMR detected proteins in the rat cerebral cortex in vivo and in vitro. NMR Biomed 6:242–247
Kilby PM, Bolas NM, Radda GK (1991) 31P-NMR study of the brain phospholipid structures in vivo. Biochim Biophys Acta 1085:257–264
Koller KJ, Zaczek R, Coyle JT (1984) N-acetyl-aspartyl-glutamate: regional levels in rat brain and the effect of brain lesions as determined by a new HPLC method. J Neurochem 43:1136–1142
Koschorek F, Gremmel H, Stelten J, Offerman W, Leibfritz D (1988) Cerebrospinal fluid: detection of tumors and disk herniations with MR spectroscopy. Neuroradiology 167:813–816
Krägeloh-Mann I, Grood W, Niemann G, Haas G, Ruitenbeck W (1992) Assessment and therapy monitoring of Leigh disease by MRI and proton spectroscopy. Pediatr Neurol 8:60–64
Krägeloh-Mann I, Grood W, Shöning M, Marquard K, Nägele T, Ruitenbeek W (1993) Proton spectroscopy in five patients with Leigh's disease and mitochondrial enzyme deficiency. Dev Med Child Neurol 35:769–776
Kreis R, Ross BD (1992) Cerebral metabolic disturbances in patients with subacute and chronic diabetes melitus: detection with proton MR spectroscopy. Radiology 184:123–130
Kreis R, Ross BD, Farrow NA, Ackerman Z (1992) Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 182:19–27
Kugel H, Heindel W, Ernestus R-I, Bunke J, Du Mesnil R, Friedmann G (1992) Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy. Radiology 183:701–709
Kuzniecky R, Elgavish GA, Hetherington HP, Evanochcko WT, Pohost GM (1992) In vivo P-31 nuclear magnetic resonance spectroscopy of human temporal lobe epilepsy. Neurology 42:1586–1590
Kwong KK, Belliveau JW, Chesler DA, Goldberg IE, Weisskoff RM, Poncelet BP, Kennedy DN, Hoppel BE, Cohen MS, Turner R, Cheng HM, Brady TJ, Rosen BR (1992) Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci USA 89:5675–5679
Larsson HBW, Christiansen P, Jensen M, Frederiksen J, Heltberg A, Olesen J, Henriksen O (1991) Localized in vivo proton spectroscopy in the brain of patients with multiple sclerosis. Magn Reson Med 22:23–31
Lassmann H, Zimprich F, Rossler K, Vass K (1991) Inflammation in the nervous system. Basic mechanisms and immunological concepts. Rev Neurol (Paris) 147:763–781
Lear JL (1990) Glycolysis: link between PET and proton MR spectroscopic studies of the brain. Radiology 174:328–330
Lee JH, Ross BD (1993) Quantitation of idiogenic osmoles in human brain. 12th Annual meeting of the Society of Magnetic Resonance in Medicine, New York. Book of abstracts, p 1553
Levine SR, Helpern JA, Welsh KMA, Vande Linde AMQ, Sawaya KL, Brown EE, Ramadan NM, Deveshwar RK, Ordidge RJ (1992) Human focal cerebral ischemia: evaluation of brain pH and energy metabolism with P-31 NMR spectroscopy. Radiology 185:537–544
Lewis AJ (1976) Mechanisms of neurological diseases. Little Brown, Boston, pp 540
Lombes A, Bonilla E, Dimauro S (1989) Mitochondrial encephalomyopathies. Rev Neurol (Paris) 145:671–689
Marks HG, Caro PA, Wang Z, Detre JA, Bogdan AR, Gusnar DA, Zimerman RA (1991) Use of computed to mography, magnetic resonance imaging and localized 1H magnetic resonance spectroscopy in Canavan's disease. A case report. Ann Neurol 30:106–110
Martin DL (1992) Synthesis and release of neuroactive substances by glial cells. Glia 5:81–94
Martin DL, Grutter R, Boesch C (1990) In vivo NMR spectroscopy: investigation of brain in neonates and infants. Pediatrie 45:677–682
Martin GB, Paradis NA, Helpern JA, Nowak RM, Welch KMA (1991) Nuclear magnetic resonance spectroscopy study of human brain after cardiac resuscitation. Stroke 22:462–468
Matson GB, Weiner MW (1992) Spectroscopy. In: Shank DD, Bradley WGJr (eds) Magnetic resonance imaging, chapter 15. Mosby-Yearbook, St Louis, pp 438–478
Matson GB, Meyerhoff DJ, Lawry TJ, Lara RS, Duijn J, Deicken R, Weiner MW (1993) Use computer simulations for quantitation of P-31 ISIS MRS results. NMR Biomed 6:215–224
Matthews PM, Andermann F, Arnold D (1990) A proton magnetic resonance spectroscopy study of focal epilepsy in humans. Neurology 40:985–989
Matthews PM, Francis G, Antel J, Arnold DL (1991) Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis. Neurology 41:1251–1256
Matthews PM, Berkovic SF, Shoubridge EA, Andermann F, Karpati G, Carpenter S, Arnold D (1991) In vivo magnetic resonance spectroscopy of brain and muscle in a type of mitochondrial encephalomyopathy (MERRF). Ann Neurol 29:435–438
Matthews WB, Compston A, Allen IV, Martyn CN (1991) McAlpine's multiple sclerosis. Churchill Livingstone, Edinburgh, pp 341–378
Maudsley AA, Hilal SK, Perman WH, Simon HE (1983) Spatially resolved high resolution spectroscopy by “four-dimensional” NMR. J Magn Res 51:147–152
Maudsley AA, Twieg DB, Sappey-Marinier D, Hubesch B, Hugg JW, Matson GB, Weiner MW (1990) Spin-echo 31P spectroscopic imaging in the human brain. Magn Reson Med 14:415–422
McCandless DW (1985) Cerebral energy and metabolic encephalopathy. Plenum Press, New York, p 456
McComb RD, Bigner DD (1984) The biology of malignant glioma: a comprehensive survey. Clin Neuropathol 3:93–106
McGeer PL, McGeer EG (1989) Aminoacids transmitters. In: Siegel G, Agranoff B, Alberts RW, Molinoff P (eds) Basic neurochemistry, 4th edn. Raven Press, New York, pp 311–332
Menon DK, Ainsworth JG, Cox IJ, Coker RC, Sargentoni J, Coutts GA, Baudouin CJ, Kocsis AE, Harris JRW (1992) Proton MR spectroscopy of the brain in AIDS dementia complex. J Comput Assist Tomogr 16:538–542
Merchant TE, Glonek T (1990) 31P NMR of phospholipids glycerol phosphodiester residues. J Lipid Res 31:479–486
Meyerhoff DJ (1993) Magnetic resonance spectroscopic imaging. In: Gillis R (ed) NMR in physiology and medicine. Academic Press, New York (in press)
Meyerhoff DJ, MacKay S, Baker A, Schaefer S, Weiner MW (1992) Magnetic resonance spectroscopy. In: Higgins CB, Hricak H, Helm CA (eds) Magnetic resonance imaging of the body, 2nd edn. Raven Press, New York, pp 287–312
Meyerhoff DJ, MacKay RDS, Grossman N, Van Dyke C, Dillon W, Fein G, Weiner MW (1992) Effects of normal ageing and Alzheimer's disease on cerebral 1H metabolites. 11th Annual meeting of the Society of Magnetic Resonance in Medicine, Berlin. Book of abstracts, p 1931
Meyerhoff DJ, MacKay S, Bachman L, Poole N, Dillon WP, Weiner MW, Fein G (1993) Reduced brain N-acetyl-aspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus seropositive individuals: in vivo 1H magnetic resonance spectroscopic imaging. Neurology 43:509–515
Michaelis T, Merboldt KD, Hänïcke W, Gyngell ML, Bruhn H, Frahm J (1991) On the identification of cere bral metabolites in localized H-1 NMR spectra of human brain in vivo. NMR Biomed 4:90–98
Michaelis T, Helms G, Merboldt KD, Hänïcke W, Bruhn H, Frahm J (1993) Identification of Scyllo-Inositol in proton NMR spectra of human brain in vivo. NMR Biomed 6:105–109
Milhorat TH, Hammock MK (1983) Cerebrospinal fluid as reflection of internal milieu of brain. In: Wood JH (eds) Neurobiology of cerebrospinal fluid, Plenum Press, London, pp 1–23
Miller BL (1991) A review of chemical issues in 1H NMR spectroscopy: N-acetyl-aspartate, creatine, and choline. NMR Biomed 4:47–52
Miller BL, Moats RA, Shonk T, Ernst T, Wooley S, Ross BD (1993) Alzheimer disease: depiction of increased myo-Inositol with proton MR spectroscopy. Radiology 187:433–437
Minderhoud JM, Mooyaart EL, Kamman RL, Teelken AW, Hoogsraten MC, Vencken LM, Gravenmade E Jr, Van den Burg W (1992) In vivo phosphorus magnetic resonance spectroscopy in multiple sclerosis. Arch Neurol 49:161–165
Minshew NJ, Goldstein G, Dombrowski SM, Panchalingam K, Pettegrew JW (1993) A preliminary 31P study of autism. Evidence of undersynthesis and increased degradation of brain membranes. Biol Psychiatry 33:762–773
Moonen CTW, Van Zijl PCM (1990) Highly effective water suppression for in vivo proton NMR spectroscopy (DRYSTEAM). J Magn Reson 88:28–41
Moorcraft J, Bolas NM, Ives NK, Ouwerkerk R, Smyth J, Rajagopalan B, Hope PL, Radda GK (1991) Global and depth resolved phosphorus magnetic resonance spectroscopy to predict outcome after birth asphyxia. Arch Dis Child 66:1119–1123
Nagai Y, Naruse S, Weiner MW (1993) Effect of hypoglycemia on changes of brain lactic acid and intracellular pH produced by ischaemia. NMR Biomed 6:1–6
Naruse S, Horikawa Y, Tanaka C, Hirakawa K, Nishikawa H, Watari H (1984) In vivo measurement of energy metabolism and the concomitant monitoring of encephalogram in experimental ischaemia. Brain Res 296:370–372
Nicoli F, Vion-Dury J, Maloteaux JM, Delwaide C, Confort-Gouny S, Sciaky M, Cozzone PJ (1993) CSF and serum metabolic profile of patients with Huntington's chorea. A study by high resolution proton NMR spectroscopy and HPLC. Neurosci Lett 154:47–51
Nielsen JB, Toft PB, Reske-Nielsen E, Jensen KE, Christiansen P, Thomsen C, Henriksen O, Lou HC (1993) Cerebral magnetic resonance spectroscopy in Rett syndrome. Failure to detect mitochondrial disorder. Brain Dev 15:107–112
Nitsch RM, Blusztajn JK, Pittas AG, Slack BE, Growdon JH, Wurtman RJ (1992) Evidence for a membrane defect in Alzheimer disease brain. Proc Natl Acad Sci USA 89:1671–1675
Nordstrom CH, Rehncrona S, Siesjo BK (1990) Cerebral metabolism. In: Youmans JR (ed) Neurological surgery, 3rd edn. Saunders, Philadelphia, pp 623–651
Norris DG, Dreher W, Leibfritz D (1993) Fast 3D and 4D proton spectroscopic imagingusing the sliced-k-space method. 12th Annual meeting of the Society of Magnetic Resonance in Medicine, New York. Book of abstracts, p 896
Ohnishi T, Posner JB, Shapiro WR (1992) Vasogenic brain edema induced by arachidonic acid: role of extracellular arachidonic acid in bloodbrain barrier dysfunction. Neurosurg 30:545–551
Peden CJ, Cowan FM, Bryant DJ, Sargentoni J, Cox IJ, Menon DK, Gadian DG, Bell JD, Dubowitz LM (1990) Proton MR spectroscopy of the brain in infant. J Comput Assist Tomogr 14:886–894
Peden CJ, Rutherford MA, Sargentoni J, Cox IJ, Bryant DJ, Dubowitz LM (1993) Proton spectroscopy of the neonatal brain following hypoxicischaemic injury. Dev Med Child Neurol 35:502–510
Perry TL, Hansen S, Beery K, Mok C, Lesk D (1971) Free aminoacids and related compounds in biopsies of the human brain. J Neurochem 18:521–528
Petroff OAC, Pritchard JW, Behar KL, Alger JR, Den Hollander JA, Shulman RG (1985) Cerebral intracellular pH by 31P nuclear magnetic resonance spectroscopy. Neurology 35:781–788
Petroff OAC, Yu RK, Ogino T (1986) High-resolution proton magnetic resonance analysis of human cerebrospinal fluid. J Neurochem 47:1270–1276
Petroff OAC, Graham GD, Blamire AM, Al Rayess M, Rothman DL, Fayad PB, Brass LM, Shulman RG, Prichard JW (1992) Spectroscopic imaging of stroke in humans: histopathology correlates of spectral changes. Neurology 42:1349–1354
Pettegrew JW, Withers G, Panchalingam K, Post JFM (1987) 31P nuclear magnetic resonance (NMR) spectroscopy of brain in ageing and Alzheimer's disease. Neural Transm [Suppl] 24:261–268
Plaitakis A (1990) Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis: an hypothesis. Ann Neurol 28:3–7
Preece NE, Williams SR, Jackson G, Duncan JS, Houseman J, Gadian DG (1991) 1-H NMR studies of viga-batrin induced increase in cerebral GABA. 10th Congress of Magnetic Resonance in Medicine, San Francisco, USA. Book of Abstracts, p 1000
Preece NE, Baker D, Butter C, Gadian DG, Urenjak J (1993) Experimental allergic encephalomyelitis raises betaine levels in the spinal cord of strain 13 guinea-pigs. NMR Biomed 6:194–200
Prichard JW (1992) Magnetic resonance spectroscopy of the brain. Clin Chim Acta 206:115–123
Prichard JW (1992) The ischaemic penumbra in stroke: prospects for analysis by nuclear magnetic resonance spectroscopy. In: Waxman SG (ed) Molecular and cellular approaches to the treatment of neurological disease. Raven Press, New York, pp 153–174
Pulsinelli WA, Cooper AJL (1989) Metabolic encephalopathies and coma. In: Siegel G, Agranoff B, Alberts RW, Molinoff P (eds) Basic Neurochemistry, 4th edn. Raven Press, New York, pp 765–781
Quarles RH, Morell P, McFarlin DE (1989) Diseases involving myelin. In: Siegel G, Agranoff B, Alberts RW, Molinoff P (eds) Basic Neurochemistry, 4th edn. Raven Press, New York, pp 697–713
Richards TL (1991) Proton NMR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression and evaluating therapy. Am J Roentgenol 157:1073–1078
Ross BD (1991) Biochemical considerations in 114 spectroscopy. Glutamate and glutamine; myo-inositol and related metabolites. NMR Biomed 4:59–63
Roth K, Hubesch B, Meyerhoff DJ, Naruse E, Gober S, Lawry TJ, Boska MD, Matson GB, Weiner MW (1989) Non invasive quantitation of phosphorus metabolites in human tissue by NMR spectroscopy. J Magn Res 81:299–311
Rothman DL, Hanstock CC, Petroff OAC, Novotny EJ, Prichard JW, Schulman RG (1992) Localized 1H NMR spectra of glutamate in the human brain. Magn Reson Med 25:94–106
Rothman DL, Petroff OAC, Behar KL, Matson RH (1993) Localized 1-H NMR measurement of γ-aminobutyric acid in human brain in vivo. Proc Natl Acad Sci USA 90:5662–5666
Ruiz-Cabello J, Cohen JS (1992) Phospholipid metabolites as indicators of cancer cell function. NMR Biomed 5:226–233
Salford LG, Plum F, Siesjö BK (1973) Graded hypoxia-oligemia in rat brain. I. Biochemical alterations and their implications. Arch Neurol 29:227–233
Salford LG, Plum F, Brierley JB (1973) Graded hypoxia-oligemiain rat brain. II. Neuropathological alter ations and their implications. Arch Neurol 29:234–238
Sappey-Marinier D, Hubesch B, Matson GB, Weiner MW (1992) Decreased phosphorus metabolite concentration and alkalosis in chronic cerebral infarction. Radiology 182:29–34
Sappey-Marinier D, Deicken RE, Fein G, Calabrese G, Hubesch B, Van Dyke C, Dillon W, Davenport L, Meyerhoff DJ, Weiner MW (1992) Alterations in brain phosphorus metabolite concentration associated with areas of high signal intensity in white matter at MR imaging. Radiology 183:247–256
Sappey-Marinier D, Calabrese G, Hetherington HP, Fisher SNG, Deicken RE, Van Dyke C, Fein G, Weiner MW (1992) Proton magnetic resonance spectroscopy of the human brain: application to the normal white matter, chronic infarction, and MRI white matter signal hyperintensities. Magn Reson Med 26:313–327
Scheinberg P (1991) The biologic basis for the treatment of acute stroke. Neurology 41:1867–1873
Shulman RG, Blamire AM, Rothman DL, McCarthy G (1993) Nuclear magnetic resonance imaging and spectroscopy of the brain function. Proc Natl Acad Sci USA 90:3127–3133
Siesjo BK (1981) Cell damage in the brain: a speculative synthesis. J Cereb Blood Flow Metab 1:155–185
Siesjo BK (1990) Calcium, excitotoxins and brain damage. Physiol Sci 5:120–125
Simmons ML, Frondoza CG, Coyle JT (1991) Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 45:37–45
Skolnick AA (1993) Magnetic resonance spectroscopy may offer early look at HIV disease-mediated changes in brain. JAMA 269:1084
Smith CD, Gallenstein LG, Layton WJ, Kryscios RJ, Markesvery WR (1993) 31-P magnetic resonance spectroscopy in Alzheimer's and Pick's disease. Neurobiol Ageing 14:85–92
Sutton LN, Wang Z, Gusnard D, Lange B, Periolongo G, Bogdan AR, Detre JA, Rorke L, Zimmerman RA (1992) Proton magnetic resonance spectroscopy of pediatric brain tumors. Neurosurgery 31:195–202
Tanaka C, Naruse S, Horikawa Y, Higushi T, Hirakawa K, Nishikawa H (1985) Investigation of pathophysiology in ischemic brain edema with 1H-NMR and 31P-NMR. In: Inaba Y (ed) Brain edema. Springer, Berlin Heidelberg New York, pp 465–473
Toole JF (1990) Cerebrovascular disorders. Raven Press, New York
Twieg DB, Meyerhoff DJ, Roth K, Sappey-Marinier D, Boska MD, Gober JR, Schaefer S, Weiner MW (1989) Phosphorus-31 magnetic resonance spectroscopy in human by spectroscopic imaging: localized spectroscopy and metabolite imaging. Magn Reson Med 12:291–305
Urenjak J, Williams SR, Gadian DG, Noble M (1992) Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J Neurochem 59:55–61
Van der Knaap MS, Van der Grond J, Van Rijen PC, Faber JAJ, Valk J, Willeme K (1990) Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain. Radiology 176:509–515
Van der Knaap MS, Van der Grond J, Luyten PR, Hollander JA den, Nauta JJP, Valk J (1992) 1H and 31P magnetic resonance spectroscopy of brain degenerative cerebral disorders. Ann Neurol 31:202–211
Van Hecke P, Marchal G, Johannick K, Demaerel P, Wilms G, Carton H, Baert AL (1991) Human brain proton localized spectroscopy in multiple sclerosis. Magn Reson Med 18:199–206
Van Zijl PCM, Moonen CTW (1992) Solvent suppression strategies for in vivo magnetic resonance spectroscopy. In: Diehl P, Fluck E, Gunther H, Kosfeld R, Seelig J (eds) NMR, basic principles and progress. Springer, Berlin Heidelberg New York, pp 67–108
Vion-Dury J, Nicoli F, Torri G, Torri J, Kriat M, Sciaky M, Davin A, Viout P, Confort-Gouny S, Cozzone PJ (1992) High resolution NMR spectroscopy of physiological fluids: from metabolism to physiology. Biochimie 74:801–807
Vion-Dury J, Confort-Gouny S, Nicoli F, Dhiver C, Gastaut JA, Gastaut Cozzone PJ (1993) Localized brain proton MRS in neurologic complications of AIDS: value for diagnosis and prognosis. 12th Annual meeting of the Society of Magnetic Resonance in Medicine, New York. Book of abstracts, p 1563
Waltz W (1989) Role of glial cells in the regulation of the brain ion microenvironment. Prog Neurobiol 33:309–333
Weiner MW, Hetherington HP (1989) The power of the proton. Radiology 172:318–320
Welch KA, Levine SR, D'Andrea G, Helpern JA (1988) Brain pH in migraine: an in vivo phosphorus-31 magnetic resonance spectroscopy study. Cephalagia 8:23–27
Welch KA, Levine SR, D'Andrea G, Schultz LR, Helpern JA (1989) Preliminary observations on brain energy metabolism in migraine studied by in vivo phosphorus-31 NMR spectroscopy. Neurology 39:538–541
Welch KMA, Levine SR, Martin G, Ordidge R, Van de Linde AQ, Helpern JA (1992) Magnetic reso nance spectroscopy in cerebral ischaemia. In: Cerebral ischaemia: treatment and prevention. Neurol Clin 10:1–29
Youngner SJ (1992) Defining death. A superficial and fragile consensus. Arch Neurol 49:570–572
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vion-Dury, J., Meyerhoff, D.J., Cozzone, P.J. et al. What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy?. J Neurol 241, 354–371 (1994). https://doi.org/10.1007/BF02033352
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02033352